| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |